Kemwell is a contract biologics development and CMO company providing services to global biologics organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing.
“Vaccine & biological therapies are expected to increase investment in R&D to create demand in CDMO industry”
Bengaluru-based Kemwell Biopharma, a biologics contract development and manufacturing service provider, is working aggressively on augmenting its existing infrastructure. In addition, the CDMO is exploring strategic partnerships with biopharma players in the ecosystem to fit out its additional capacity which can be executed within 12-15 months.
How can we make the Indian Pharma Manufactures Atmanirbhar in a true way?
The government plans to develop three mega bulk drug parks, which will be set up at a cost of Rs 14,300 Cr in association with various states to produce chemicals for life-saving drugs and reduce their imports from China.
We are professional and reliable provider since we offer customers the most powerful and beautiful themes. Besides, we always catch the latest technology and adapt to follow world’s new trends to deliver the best themes to the market.
Read More ->